209 related articles for article (PubMed ID: 23746181)
1. Institutional profile: the Wolfson Centre for Personalised Medicine, University of Liverpool, Liverpool, UK.
Alfirevic A; Carr DF; Miyajima F; Pushpakom S; Sutton L; Jorgensen AL; Pirmohamed M
Pharmacogenomics; 2013 Jun; 14(8):861-7. PubMed ID: 23746181
[TBL] [Abstract][Full Text] [Related]
2. Translational bioinformatics and systems biology approaches for personalized medicine.
Yan Q
Methods Mol Biol; 2010; 662():167-78. PubMed ID: 20824471
[TBL] [Abstract][Full Text] [Related]
3. [Translational approach for pharmacogenomics and personalized medicine].
Zhang W; Zhou HH
Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
[TBL] [Abstract][Full Text] [Related]
4. A hub for bench-to-bedside pharmacogenomic-based research.
Voora D; Ginsburg GS
Pharmacogenomics; 2011 Aug; 12(8):1095-8. PubMed ID: 21843063
[TBL] [Abstract][Full Text] [Related]
5. Prospects for translational regenerative medicine.
Chen FM; Zhao YM; Jin Y; Shi S
Biotechnol Adv; 2012; 30(3):658-72. PubMed ID: 22138411
[TBL] [Abstract][Full Text] [Related]
6. Translational medicine meets new technologies for enabling personalized care.
Blobel B
Stud Health Technol Inform; 2013; 189():8-23. PubMed ID: 23739350
[TBL] [Abstract][Full Text] [Related]
7. Strategies for personalized medicine-based research and implementation in the clinical workflow.
Lieb W; Völzke H; Pulley JM; Roden DM; Kroemer HK
Clin Pharmacol Ther; 2012 Oct; 92(4):443-5. PubMed ID: 22910438
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomic biomarkers for personalized medicine.
Chen JJ; Lin WJ; Chen HC
Pharmacogenomics; 2013 Jun; 14(8):969-80. PubMed ID: 23746190
[TBL] [Abstract][Full Text] [Related]
9. From bench to bedside and to health policies: ethics in translational research.
Petrini C
Clin Ter; 2011; 162(1):51-9. PubMed ID: 21448547
[TBL] [Abstract][Full Text] [Related]
10. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
11. Medical education research in the context of translational science.
Santen SA; Deiorio NM; Gruppen LD
Acad Emerg Med; 2012 Dec; 19(12):1323-7. PubMed ID: 23279241
[TBL] [Abstract][Full Text] [Related]
12. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
[TBL] [Abstract][Full Text] [Related]
13. Institutional profile: integrated center for research and treatment of vertigo, balance and ocular motor disorders.
Brandt T; Zwergal A; Jahn K; Strupp M
Restor Neurol Neurosci; 2010; 28(1):135-43. PubMed ID: 20086290
[TBL] [Abstract][Full Text] [Related]
14. Toward personalized medicine in the neuropsychiatric field.
Wong EH; Fox JC; Ng MY; Lee CM
Int Rev Neurobiol; 2011; 101():329-49. PubMed ID: 22050858
[TBL] [Abstract][Full Text] [Related]
15. Translational discoveries, personalized medicine, and living biobanks of the future.
Lisanti MP; Tanowitz HB
Am J Pathol; 2012 Apr; 180(4):1334-6. PubMed ID: 22453029
[No Abstract] [Full Text] [Related]
16. Regulatory Science - An Underappreciated Component of Translational Research.
Rouse R; Zineh I; Strauss DG
Trends Pharmacol Sci; 2018 Mar; 39(3):225-229. PubMed ID: 29329784
[TBL] [Abstract][Full Text] [Related]
17. Knowledge translation for nephrologists: strategies for improving the identification of patients with proteinuria.
Hemmelgarn BR; Manns BJ; Straus S; Naugler C; Holroyd-Leduc J; Braun TC; Levin A; Klarenbach S; Lee PF; Hafez K; Schwartz D; Jindal K; Ervin K; Bello A; Turin TC; McBrien K; Elliott M; Tonelli M;
J Nephrol; 2012; 25(6):933-43. PubMed ID: 23065921
[TBL] [Abstract][Full Text] [Related]
18. Institutional profile: The Carney Centre for Pharmacogenomics: a New Zealand focus for personalized medicine research.
Kennedy MA; Joyce PR; Begg EJ
Pharmacogenomics; 2012 Jun; 13(8):865-8. PubMed ID: 22676191
[TBL] [Abstract][Full Text] [Related]
19. Company profile: Sequenom, Inc.
Cantor CR
Pharmacogenomics; 2012 Apr; 13(5):529-31. PubMed ID: 22462745
[TBL] [Abstract][Full Text] [Related]
20. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
